COMPANIES

Australia is home to many reputable Contract Research Organisations
(CROs), carrying out approximately 1,000
new clinical trials started in Australia each year by both local and global
pharmaceutical, biotech and medical device companies. Our report 'Clinical
Trials in Australia: the economic profile and competitive position of the
sector', is a comprehensive overview of the entire clinical trials landscape in
Australia, giving insight into our strengths and areas to improve.

Australia is an attractive environment for innovation,
investment and collaboration in R&D and clinical trials, and offers:

A fast approvals process for clinical trials

Directly transferable trial protocols for other
jurisdictions

Socio-political stability

World-class healthcare and medical research
infrastructure

Strong networks and collaboration between
research centres, universities, community health networks and hospitals

An educated and qualified workforce

An internationally respected approval system for
new drugs and devices

Strong IP procedures

Generous tax incentives for R&D

A culturally diverse population

Australia is home to 22 of the world’s top 400 universities,
and CSIRO ranks in the top one-per-cent of the world’s scientific institutions
in 14 of 22 fields. Health and medical research is one of the strongest research
disciplines in Australia, with over 60-per-cent of research outputs ranked as
‘above’ or ‘well above world standard’. Medical research is responsible for a
quarter of all patents granted and almost half of all research
commercialisation income achieved in 2015-16 in Australia.

Australia is also well-known for its world class Cooperative
Research Centres (CRCs) and medical precincts, establishing agile collaborative
partnerships between sector participants to create translational research and
development of market-ready, clinically tested medtech innovations.

Australian clinical data and results are accepted by
international regulatory agencies, following the highest level of ISO good
clinical practice standards. View Austrade’s ‘Clinical Trials Capability Report’
for more information about investment and trial opportunities within Australia.